Description
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Cas No. | 1168091-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H14FIN4O3 |
Formula Wt. | 456.21 |
IUPAC Name | 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide |
Solubility | DMSO 91 mg/mL warmed (199.46 mM) Ethanol 5 mg/mL warmed (10.95 mM) Water Insoluble |
Appearance | Beige Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Hatzivassiliou G, Haling JR, Chen H, et al. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature. 2013 Sep 12;501(7466):232-6. PMID: 23934108.
HSP90 inhibitor.
For use in amino acid analysis.
Chk1 inhibitor.
Furocoumarin; voltage-gated Na+ channel blocker...
PLK1 inhibitor.
Alkaline phosphatase substrate used to quantify...
Bisphosphonate.
Taxane found in Taxus; DNA polymerase inhibitor...
STING inhibitor
Bioactive compound from olive tree.
Chalcone; SIRT activator, GABA-A positive modul...
Triterpene saponin originally found in Bolboste...
Tamoxifen analog; SERM.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Derivative of aristolochic acid found in Asarum...
CB1 inverse agonist.
Thiazolidine; Pim kinase inhibitor.
Antimicrobial peptide, generated during fibrin ...
Polycationic aminoglycoside; protein translatio...
Cannabinoid receptor 2 selective agonist.